Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: AbbVie Ltd., Maidenhead, SL6 4UB, United Kingdom
Sevoflurane.
| Pharmaceutical Form |
|---|
|
Sevoflurane is a nonflammable volatile liquid. Sevoflurane is administered via inhalation of the vaporised liquid. |
The finished product is comprised only of the active ingredient (sevoflurane).
| Active Ingredient | Description | |
|---|---|---|
| Sevoflurane |
Sevoflurane is used as an inhalational anaesthetic for induction and maintenance of general anesthesia. As with all other inhalation agents sevoflurane depresses cardiovascular function in a dose related fashion. In patients with normal intracranial pressure (ICP), sevoflurane had minimal effect on ICP and preserved CO2 responsiveness. |
| List of Excipients |
|---|
|
Water (as a Lewis Acid Inhibitor). |
100ml and 250ml amber polyethylene napthalate (PEN) bottles.
Not all pack sizes may be marketed.
AbbVie Ltd., Maidenhead, SL6 4UB, United Kingdom
PL 41042/0004
1 September 1995
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
